Single-use technologies have become a focal standard in biopharmaceutics. Compliance with cGMP criteria is also a matter of ...
Oliver Blum (in the above photo on the right), who has been working for Endress+Hauser since 2005, brings with him almost 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback